Search research articles
Contact Us
Filters
Showing results (51-60 of 209) with videos related to
Page
of 21
Sort By:
Journal of Clinical and Experimental Hepatology
|
August 6, 2016
Acute Liver Failure Caused by Hepatitis A Virus with Dengue Coinfection
Sunil Taneja, Amritangsu Borakokty, Ajay Duseja, et al.
Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation
|
December 5, 2014
Congenital hepatic fibrosis with extra-hepatic porto-systemic shunt and hepatopulmonary syndrome successfully managed with living related liver transplantation
Sunil Taneja, Manavwadhawan, Subash Gupta, et al.
Hepatology (Baltimore, Md.)
|
January 10, 2022
Reply
Sarah Wang, Reid Whitlock, Jennifer C Lai, et al.
Current Microbiology
|
January 4, 2022
NLRP3 Inflammasome Activation is a Prognostic Marker of Recovery in HEV-Infected Patients
Vikram Thakur, Radha Kanta Ratho, Mini P Singh, et al.
Diabetes & Metabolic Syndrome
|
November 30, 2022
Indian patients with human immunodeficiency virus infection have high prevalence but mild severity of non-alcoholic fatty liver disease
Arka De, Ajay Duseja, Prayas Badhala, et al.
Journal of Clinical and Experimental Hepatology
|
December 23, 2016
Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-An Experience from a Tertiary Care Hospital
Sunil Taneja, Sunil Tohra, Ajay Duseja, et al.
Hepatology Communications
|
May 4, 2022
Immune-mediated liver injury following COVID-19 vaccination: A systematic review
Akash Roy, Nipun Verma, Surender Singh, et al.
Journal of Clinical and Experimental Hepatology
|
October 18, 2016
Honeycomb Cyst of the Liver
Sunil Taneja, Pramod Kumar, Ajay Duseja, et al.
Journal of Gastroenterology and Hepatology
|
September 15, 2016
Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C
Sandeep Satsangi, Manu Mehta, Ajay Duseja, et al.
Journal of Clinical and Experimental Hepatology
|
July 1, 2017
Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist?
Manu Mehta, Sandeep Satsangi, Ajay Duseja, et al.
Page
of 21
Search research articles
Search
Showing results (51-60 of 209) with videos related to
Sort By:
Page
of 21
Journal of Clinical and Experimental Hepatology
|
August 6, 2016
Acute Liver Failure Caused by Hepatitis A Virus with Dengue Coinfection
Sunil Taneja, Amritangsu Borakokty, Ajay Duseja, et al.
Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation
|
December 5, 2014
Congenital hepatic fibrosis with extra-hepatic porto-systemic shunt and hepatopulmonary syndrome successfully managed with living related liver transplantation
Sunil Taneja, Manavwadhawan, Subash Gupta, et al.
Hepatology (Baltimore, Md.)
|
January 10, 2022
Reply
Sarah Wang, Reid Whitlock, Jennifer C Lai, et al.
Current Microbiology
|
January 4, 2022
NLRP3 Inflammasome Activation is a Prognostic Marker of Recovery in HEV-Infected Patients
Vikram Thakur, Radha Kanta Ratho, Mini P Singh, et al.
Diabetes & Metabolic Syndrome
|
November 30, 2022
Indian patients with human immunodeficiency virus infection have high prevalence but mild severity of non-alcoholic fatty liver disease
Arka De, Ajay Duseja, Prayas Badhala, et al.
Journal of Clinical and Experimental Hepatology
|
December 23, 2016
Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-An Experience from a Tertiary Care Hospital
Sunil Taneja, Sunil Tohra, Ajay Duseja, et al.
Hepatology Communications
|
May 4, 2022
Immune-mediated liver injury following COVID-19 vaccination: A systematic review
Akash Roy, Nipun Verma, Surender Singh, et al.
Journal of Clinical and Experimental Hepatology
|
October 18, 2016
Honeycomb Cyst of the Liver
Sunil Taneja, Pramod Kumar, Ajay Duseja, et al.
Journal of Gastroenterology and Hepatology
|
September 15, 2016
Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C
Sandeep Satsangi, Manu Mehta, Ajay Duseja, et al.
Journal of Clinical and Experimental Hepatology
|
July 1, 2017
Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist?
Manu Mehta, Sandeep Satsangi, Ajay Duseja, et al.
Page
of 21